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Objective: African American patients have been underrepresented in large-scale trials of carotid endarterectomy (CEA).
Thus the role of CEA in the treatment of extracranial carotid artery occlusive disease in black patients remains unclear.
We undertook this study to determine the effect of black race on early and late outcome of CEA.
Methods: A retrospective review was performed of records for patients who underwent CEA from 1990 to 1999. Data on
demographics, operative indications, hospital course, and long-term follow-up were obtained for each patient. Patients
were stratified by race for comparison of perioperative course and late outcome. Risk factors were compared using 2
methods, and life table analysis was performed with Kaplan-Meier survival plots.
Results: One thousand forty-five CEA procedures were performed during the study period, 133 (13%) in black patients
and 912 (87%) in white patients. Demographic risk factors were similar in both groups, except for hypertension (P 
.003), diabetes (P < .001), and renal insufficiency (P  .03), which were more prevalent in blacks. Just over half of
patients had symptoms at presentation, with equal racial distribution. The perioperative stroke and death rate was 3.3%
(blacks, 5.3%; whites, 3.1%; P .19). The 8-year actuarial ipsilateral stroke rate was 7% in patients without symptoms and
8% in patients with symptoms, with no racial variation. There was, however, a racial difference in the long-term “all
strokes” rate (P  .002), regardless of vascular territory. This difference was largely due to the high late stroke rate in
black patients with symptoms at presentation. A Cox proportional hazards analysis showed that only black race was a
significant predictor of any stroke.
Conclusions: CEA can be accomplished with acceptable morbidity and mortality in black patients with an expectation of
similar protection from ipsilateral ischemic stroke as in white patients. Black patients, however, have a higher incidence
of all strokes at long-term follow-up due to the higher risk of stroke in patients with symptoms of carotid bifurcation
disease. (J Vasc Surg 2003;38:129-37.)
The stroke burden remains heavy in African American
patients. Despite a continuing decline in the overall inci-
dence and mortality of stroke, black patients continue to
experience more strokes than do white patients, with dis-
proportionately higher morbidity and mortality.1,2 Efforts
to reduce this burden have largely focused on identification
and control of associated risk factors, the most important of
which is hypertension. Carotid endarterectomy (CEA),
extremely effective in stroke prevention, has been relatively
underutilized in this population. In the large, randomized,
prospective trials that unequivocally established the bene-
fits of CEA for treatment of both symptomatic and
asymptomatic carotid stenosis, black patients constituted
only 3% of participants.3,4 In addition, several epidemi-
ologic studies have demonstrated that, despite the
higher incidence of ischemic stroke, CEA is performed
much less frequently in black patients than in white
patients.5-9 Whether this racial disparity in endarterec-
tomy performance results from appropriate application
of evidence-based medicine, racial bias in referral or
selection of patients, or some other cause is unclear. The
most frequently cited explanation is the known racial
variation in the pattern of carotid artery disease. Black
patients are more likely to have intracranial disease,
whereas white patients usually have extracranial disease.
As a result, blacks less frequently have a carotid lesion
amenable to endarterectomy, and those who do may be
at increased risk for postoperative morbidity and mortal-
ity secondary to intracranial disease.10-13 Another expla-
nation centers on increased prevalence of comorbid con-
ditions, eg, hypertension and diabetes, which place black
patients at higher operative risk. Two recent series have
documented higher perioperative stroke and death rates
in black patients undergoing CEA, and a third study
showed an equivalent outcome in black and white pa-
tients.14-16 The mere perception of increased procedural
risk in blacks could lead to referral and selection bias that
would limit application of CEA.9
The present study was undertaken to determine the
outcome of CEA in black patients. Racial differences in
both perioperative and late outcome were examined to
better define the relative effectiveness of endarterec-
tomy. Such data should be helpful in establishing guide-
lines for the most appropriate use of CEA in this high-
risk population.
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METHODS
Patients. Henry Ford Hospital is a large, urban, ter-
tiary care referral medical center. It is the central hub of a
healthcare system that serves a population base of approx-
imately 4 million patients in southeast Michigan. Use of the
computerized vascular surgery registry and institutional
operative logs enabled identification of all patients who
underwent CEA for extracranial carotid artery atheroscle-
rotic occlusive disease on the vascular surgery service be-
tween January 1990 and December 1999. Of 1000 consec-
utive patients identified, 76 were excluded from further
study because of Asian, Hispanic, or unknown race. The
remaining 924 patients underwent 1045 CEAs during the
study period. The decision to operate was based on patient
symptomatology and carotid imaging studies, including
duplex ultrasound scanning and cerebral arteriography,
following guidelines similar to the recommendations of the
Asymptomatic Carotid Atherosclerosis Study (ACAS)3 and
the North American Symptomatic Carotid Endarterectomy
Trial (NASCET).4 Patients undergoing simultaneous sub-
clavian or cardiac revascularization procedures were ex-
cluded from analysis, as were those with recurrent carotid
artery stenosis. Individual CEAs were counted separately so
that patients undergoing staged, bilateral procedures were
recorded and evaluated as two entries. Standard sociode-
mographic data; preoperative, perioperative, and postoper-
ative data; and stroke information were recorded for each
patient. Dyslipidemia was not included in the analysis be-
cause during the study period many patients were given
lipid-lowering agents regardless of cholesterol levels.
Operative procedure. Endarterectomy was per-
formed, with most patients under general anesthesia, with
continuous electroencephalographic (EEG) monitoring.
Selective shunting was used based on EEG changes or the
neurologic status of an awake patient. Arteriotomies were
closed either primarily or with patch angioplasty, based on
internal carotid arterial diameter and surgeon preference.
Internal, external, and common carotid artery signals were
evaluated with a sterile continuous-wave Doppler flow
probe prior to wound closure to ensure adequate flow
across the endarterectomy site. Postoperatively, patients
were monitored in a surgical step-down unit for 24 hours.
The institution of a CEA clinical pathway in 1996 led to a
significant decrease in length of hospital stay, and most
patients were discharged to home on the first postoperative
day.
Perioperative outcome. Death, stroke, and other
procedural complications occurring within 30 days of sur-
gery were tabulated for all patients. Perioperative stroke
was defined as any focal neurologic deficit with abrupt
onset that persisted longer than 24 hours, regardless of
subtype (ischemic, hemorrhagic) or brain anatomic loca-
tion (cortical, subcortical, posterior circulation).
Postoperative follow-up. Patients were routinely
evaluated in the outpatient clinic at 6 weeks and 1 year after
CEA with carotid duplex scanning and neurologic exami-
nation. Those with significant contralateral disease were
followed for longer intervals. Long-term follow-up in-
volved a review of all outpatient clinic visits and hospital
admissions documented in our system-wide electronic
medical record. Late stroke was identified through a review
of brain imaging studies and clinical neurologic assess-
ments. Brain imaging studies were available for 91% of
patients (83 of 90) with stroke during follow-up. Ipsilateral
ischemic stroke was defined as any hemispheric ischemic
stroke involving the side of operation. The designation “all
strokes” referred to any postoperative stroke, regardless of
location, etiology, or interval after surgery. Patients were
also evaluated for stroke-free survival, which included all
strokes and deaths from any cause during follow-up. Pa-
tient profiles were evaluated to determine predictors of
postoperative stroke and death, long-term ipsilateral isch-
emic stroke, and all strokes during the follow-up period.
Statistical analysis. Patient sociodemographic and
risk factor data associated with perioperative morbidity and
mortality were evaluated with the 2 test with or without
Yates correction, Fisher exact test, Student t test, and
Mann-Whitney U test, as appropriate. Relative risk and
confidence intervals were determined with a logistic regres-
sion model with 2 analysis for data with constant fol-
low-up and with a Cox proportional hazards model for data
with variable follow-up. Actuarial survival analysis was per-
formed with Kaplan-Meier life tables with Mantel-Cox
log-rank univariate analysis to identify differences between
black patients and white patients. P  .05 was considered
significant for all statistical analyses.
RESULTS
During the study 924 patients underwent 1045 CEA
procedures, 912 (87%) in white patients and 133 (13%) in
black patients, with an equal percentage (23%) of bilateral
operations in each cohort. Patients were more frequently
men (male-female ratio, 1.6:1), with a mean age of 69 years
(range, 36-88 years). Risk factors did not differ by race,
except for hypertension, diabetes, and renal insufficiency
(serum creatinine concentration  1.5 mg/dL), which
were more prevalent in the black population. There was a
significant difference in insurance status, with a higher
frequency of government-based coverage (Medicare or
Medicaid) for blacks and commercial carriers for whites.
Five hundred fifty-seven patients (53%) had symptomatic
disease at presentation, with no difference by race. Signifi-
cantly more black patients, however, presented with recent
stroke (within 90 days) as the indication for CEA, com-
pared with transient ischemic attack (TIA) or amaurosis
fugax in white patients (Table I).
Ninety-three major postoperative complications devel-
oped, 12 (9%) in black patients and 81 (9%) in white
patients (Table II). Seven patients died within the first 30
postoperative days, and 2 additional patients died after 30
days but within the same hospital stay (3 [2%] blacks, 6
[0.7%] whites; P  .07). Six deaths were secondary to
perioperative stroke, 2 were related to postoperative myo-
cardial infarction, and 1 patient died of pulmonary embo-
lism after a complicated hospital course. Development of an
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institutional CEA pathway in 1996 led to a decreased
postoperative hospital stay for both blacks and whites, with
no difference between the two groups. There were also no
clinical differences in hospital charges or discharge disposi-
tion (Table II). Follow-up data were available for 1009 of
1045 CEAs (97%), with equal racial distribution. Mean
follow-up was 52.1 months in blacks and 52.6 months in
whites (P  .91) (range, 1 month-12 years). During this
period 154 patients died (17%), including 19 (16%) blacks
and 135 (17%) whites (P  .53). Causes of late death are
summarized in Table III. The “Other” category included
patients in whom no cause of death was determined, as well
as several miscellaneous causes such as gastrointestinal
bleeding, amyloidosis, and trauma.
Ninety strokes were identified during the perioperative
and late follow-up periods; however, only 51 of these were
ischemic injuries involving the cerebral hemisphere ipsilat-
eral to the endarterectomy. Twenty-six patients (6 [4.5%]
black, 20 [2.2%] white; P  .14) had ipsilateral ischemic
events during the 30-day perioperative period, and 25
patients had ipsilateral ischemic events during late follow-
up. Although the rate of all strokes was significantly differ-
ent between the two groups (P  .002), there was no
difference in perioperative stroke and death rates or long-
term ipsilateral ischemic stroke rate (Table IV).
Possible predictors of perioperative stroke and/or
death were evaluated with logistic regression analysis. Only
preoperative TIA as an indication for endarterectomy im-
parted significant risk during the perioperative period (Ta-
ble V). No predictive factors were identified for ipsilateral
ischemic stroke, either early or late (Table VI). When
patient characteristics were analyzed for all postoperative
strokes regardless of type, location, or follow-up interval,
only black race was a significant predictor (Table VII).
Kaplan-Meier survival curves were generated to evalu-
ate racial differences in ipsilateral ischemic stroke-free rate,
all stroke-free rate, and long-term stroke-free survival for
patients with asymptomatic disease (Fig 1), symptomatic
disease (Fig 2), and for all patients undergoing CEA (Fig
3). In patients with a symptomatic disease, 8-year ipsilateral
ischemic stroke-free rate was 93%, all stroke-free rate was
90%, and stroke-free survival rate was 67%, compared with
92%, 86%, and 66%, respectively, in patients with symptom-
atic disease. There was no racial difference in ipsilateral
ischemic stroke-free rate or stroke-free survival for patients
with symptomatic and asymptomatic disease. However,
there was a difference when all strokes were evaluated (P
.002), largely due to increased event rate in black patients
with symptomatic disease.
DISCUSSION
Despite a major public health effort to control associ-
ated risk factors, stroke remains the third leading cause of
death in the United States and is the leading source of
major disability.17 African Americans bear a disproportion-
ate share of this burden. Not only does stroke occur more
frequently in blacks, but it is associated with greater mor-
bidity, mortality, and recurrence than in whites.1,2 Despite
these sobering statistics, CEA continues to be peformed
substantially less frequently in black patients than in white
patients.5-8 Conventional teaching states that this disparity
is appropriate because of widely recognized racial differ-
ences in the pattern of cervicocranial atherosclerosis: black
patients have more intracranial disease and less extracranial
carotid disease when compared with white patients.10-13
These conclusions regarding the distribution of cerebral
atherosclerosis, however, are largely based on either au-
topsy series of stroke deaths or radiographic studies of
symptomatic disease.10,12,18-20 Population-based studies
of patients with asymptomatic disease confirm the observa-
tion that blacks have more intracranial disease than do
whites, but these studies have not demonstrated a signifi-
cant difference from whites with regard to extracranial
carotid disease.21,22 The risk factor basis for these findings
is well-described. Black patients have a higher incidence of
hypertension and diabetes mellitus, compared with white
patients, but an equal incidence of dyslipidemia. Both
hypertension and diabetes have been linked to the develop-
ment of atherosclerotic disease in branch vessels of the main
cerebral arteries, and dyslipidemia is a risk factor for ex-
tracranial carotid plaque formation.10,23 The end result is
that blacks have a high prevalence of risk factors associated
with both intracranial and carotid bifurcation occlusive
disease.
The misperception that blacks have less extracranial
disease than whites may be responsible for referral bias.
Previous work has documented that black patients admit-
ted with stroke undergo carotid imaging studies signifi-
cantly less frequently than do white patients; even when
carotid bifurcation disease is identified, black patients are
Table I. Gender, demographic, insurance, and
preoperative indications stratified by race
Black patients
(n  133)
White patients
(n  912)
P*n % n %
Gender
Female 58 44 339 37 .15
Male 75 56 573 63
Demographics
Age (SD) 67.8  9.8 69.1  9.1 .15
Cardiac disease 62 47 470 52 .29
Hypertension 110 83 639 70 .003
Diabetes 51 38 211 23 <.001
Smoking 70 53 472 52 .85
Renal insufficiency 15 11 56 6 .03
Previous stroke 34 26 230 24 .72
Insurance
Government 86 67 487 54 .006
Commercial 42 33 412 46
Preoperative indications
Asymptomatic 64 48 424 46 .79
Stroke 32 24 109 12 <.001
Transient ischemic attack 22 17 215 24 .10
Amaurosis fugax 15 11 143 16 .36
Vertebrobasilar 0 0 21 2 .25
*Determined with 2 analysis and Student t tests.
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less likely to undergo CEA than are white patients.24 This
latter finding may be the result of selection bias. If black
patients are considered at high risk from CEA, referring
physicians or operating surgeons may be less likely to offer
operative intervention. Together, referral and selection bias
may account for much of the racial disparity in utilization of
CEA. Patient preference also is important in this dispari-
ty.25 Racial variations in performance of other invasive
vascular procedures, eg, cardiac catheterization and coro-
nary artery bypass grafting, have also been described.26-28
Do black patients have a worse outcome after CEA?
Evidence from the literature is conflicting.7,14,15 Rigdon et
al15 examined a cohort of 104 black patients at a single
academic medical center and found that they had a higher
incidence of perioperative stroke and death compared with
a white cohort. The adverse outcome in this series was
largely due to poor results in black women, whereas black
men had perioperative stroke and death rates similar to
whites.15 Dardik et al14 reviewed a 5-year statewide expe-
rience with CEA and documented a significantly higher
perioperative stroke rate in black patients (3.1%) than in
white patients (1.6%) (P  .006). Analysis of their data,
however, revealed that much, if not all, of the poor out-
come in blacks may have been due to inferior surgical care.
The authors noted that blacks were much more likely than
whites to undergo CEA performed by a low-volume sur-
geon in a low-volume hospital, two well-recognized inde-
pendent risk factors for bad outcome. Hsia et al7 described
changing CEA trends over 10 years ending in 1996. Dur-
ing the early years of the survey blacks had a higher periop-
erative stroke and death rate than did whites; however, as
the number of CEA increased, these rates improved and
eventually began to converge. Two recent studies found no
significant differences in CEA outcome between white and
black patients.16,29 In reviewing a 3-year experience at 132
Veterans Administration Medical Centers, Horner et al16
Table II. Complications and postoperative data
Total patients Black patients White patients
P*n % n % n %
Complications
Stroke 32 3 6 4.5 26 2.9 .31
Transient ischemic attack 6 0.5 0 0 6 0.66 .35
Myocardial infarction 11 1.1 2 1.5 9 1.0 .59
Cranial nerve palsy 26 2.5 3 2.3 23 2.5 .85
Repeat operation because of bleeding 18 1.7 1 0.8 17 2 .36
Death 9 0.9 3 2.2 6 0.7 .07
Postoperative data
Hospital stay (1996) 1.8 2.3 1.7 .07
Hospital charges $12,380 $12,910 $12,307 .50
Discharged to home 999 98 119 96 880 98 .08
*Determined with 2 analysis and Student t tests.
Table III. Causes of late death (per patient)
Black
patients
(n  118)
White
patients
(n  806)
P*n % n %
Cardiac 7 6 40 5 .84
All strokes 3 3 13 2 .74
Cancer 4 3 34 4 .84
Sepsis 3 3 4 1 .12
Pulmonary 2 2 17 2 .97
Other 0 0 27 3
*Determined with 2 analysis with Yates correction for continuity.
Table IV. Perioperative and late neurologic outcome
Outcome
Total
patients
(n  1045)
Black
patients
(n  133)
White
patients
(n  912)
Pn % n % n %
Perioperative stroke
or death
35 3.3 7 5.3 28 3.1 .19
Late ipsilateral
stroke
25 2.4 5 3.8 20 2.2 .27
All strokes 90 8.6 21 15.8 69 7.6 .002
*Determined with 2 analysis.
Table V. Predictors of perioperative stroke or death as
determined with logistic regression analysis
Risk factor Odds ratio
Confidence
interval P
Male gender .92 .46-1.82 .80
Hypertension .86 .42-1.77 .68
Diabetes 1.39 .67-2.87 .38
History of stroke 1.08 .50-2.34 .84
Cardiac disease .81 .41-1.59 .53
Smoking .61 .31-1.21 .16
Renal insufficiency .83 .19-3.52 .80
Preoperative stroke 1.63 .70-3.82 .26
Preoperative trancient
ischemic attack
2.35 1.18-4.70 .02
Black race .57 .24-1.33 .20
Age 75 y 1.08 .52-2.24 .83
Medicare insurance 1.14 .57-2.28 .72
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documented a stroke or death rate of 3.8% in black patients,
not significantly different from that in white patients
(2.6%). In addition, after reviewing a nationwide database,
Lanska and Kryscio29 found no racial difference in hospital
mortality after CEA.
The results of the current series showed no significant
racial differences in perioperative stroke and death rates.
The combined stroke and death rate for the entire popula-
tion was 3.3%, comparable to the standards set by ACAS
and NASCET. More than half of our patients had preop-
erative symptoms. The breakdown in symptom type was
similar to previous reports14,16,24 in that stroke was more
likely the indication for CEA in black patients (P  .001),
compared with TIA (P .07) or amaurosis fugax (P .39)
in white patients. When stratified by patient symptom
status, as expected, perioperative stroke and death rates
were higher in patients with symptomatic disease (8.7%
black, 4.5% white) than in those with asymptomatic disease
(1.6% black, 1.4% white). Again, these differences were not
significant; however, the low power associated with this
subset analysis suggests that the results should be inter-
preted cautiously. The only positive predictor of perioper-
ative stroke or death at multivariate analysis was TIA as the
indication for endarterectomy. The low incidence of peri-
operative problems in black patients with asymptomatic
disease was gratifying and suggests that more aggressive
application of ACAS guidelines in black patients may be
warranted.
The ultimate goal of CEA is reduction of late ipsilateral
stroke rates. The ACAS trial showed actuarial improvement
in 5-year risk from 11% for medical management to 5.1%
for operative intervention.3 The late ipsilateral stroke rate
for our asymptomatic cohort was 2.4%, with no difference
between blacks and whites. When perioperative stroke and
death rates were combined with late ipsilateral stroke rate,
the overall failure rate of CEA was 5.7%, with no difference
between blacks and whites (9% black, 5% white; P  .09).
These data support a continued role for CEA in both black
and white patients.
To our knowledge, no previous studies have examined
racial differences in the long-term efficacy of CEA. The
8-year actuarial ipsilateral stroke rate for patients with
asymptomatic disease in this series was 7%, with no differ-
ence between blacks and whites. This result is comparable
to the 5-year rate of 5.1% reported by ACAS.3 When all
strokes were considered, the 8-year actuarial stroke rate was
11%, with no difference by race. Finally, stroke-free survival
rate in patients with asymptomatic disease was 80% at 5
years and 67% at 8 years, with no significant racial variation.
Again, these results are similar to those reported by ACAS,
validating the benefit of CEA in black patients with asymp-
tomatic disease.
The 8-year actuarial ipsilateral stroke rate for patients
with symptomatic disease was 8%, with no racial difference.
This is better than the 2-year ipsilateral stroke rate of 9%
reported by the NASCET trial.4 When all strokes were
evaluated, 2-year and 8-year actuarial stroke rates were 8%
and 14%, respectively, again better than the NASCET
data.4 However, when stratified by race, the long-term
stroke rate showed a 20% difference between whites and
blacks (P .004). The importance of race as a predictor of
future stroke was further confirmed by Cox proportional
hazard analysis. Despite this increased risk, CEA afforded
comparable ipsilateral stroke protection to black patients,
suggesting that these events were not secondary to ipsilat-
eral intracranial disease or recurrent carotid stenosis. The
high overall stroke risk observed in black patients with
symptomatic disease remains of concern. Analysis of brain
imaging studies revealed that most of these strokes were
ischemic and located in the contralateral hemisphere. The
possibility that these patients had untreated contralateral
carotid disease is intriguing and warrants further study.
Stroke-free survival was 87% at 2 years and 66% at 8
years, with no racial variation. These results are comparable
to the 2-year stroke-free survival rate of 84% reported by
NASCET.4 This similarity between white and black pa-
tients in stroke-free survival is surprising given the well-
recognized reduced life expectancy for blacks and the
Table VI. Predictors of ipsilateral stroke as determined
with Cox proportional hazard analysis
Risk factor
Coefficient
of variance
95% confidence
interval P
Female gender 1.026 .574-1.833 .93
Hypertension (absent) 1.306 .700-2.437 .40
Diabetes (absent) .804 .425-1.524 .50
History of stroke (absent) 1.433 .718-2.857 .31
Cardiac disease (absent) 1.018 .573-1.810 .95
Smoking (absent) .951 .534-1.692 .86
Renal insufficiency (absent) .840 .292-2.418 .75
Preoperative asymptomatic
disease (absent)
1.219 .503-2.955 .66
Preoperative stroke (absent) .587 .219-1.573 .29
Preoperative transient
ischemic attack (absent)
.573 .241-1.364 .21
Black race 1.679 .817-3.447 .16
Age 1.017 .978-1.058 .40
Medicare insurance 1.294 .644-2.601 .47
Table VII. Predictors of any stroke as determined with
Cox proportional hazards analysis
Risk factor
Coefficient
of variance
95% confidence
interval P
Female gender .855 .680-1.665 .49
Hypertension (absent) 1.129 .570-1.467 .63
Diabetes (absent) .686 .817-2.110 .12
History of stroke (absent) 1.317 .566-1.571 .29
Cardiac disease (absent) 1.104 .594-1.410 .66
Smoking (absent) .983 .491-1.170 .94
Renal insufficiency (absent) .878 .521-2.645 .75
Preoperative stroke (absent) .630 1.156-3.353 .21
Preoperative transient
ischemic attack (absent)
.629 1.069-2.727 .16
Black race 1.928 .258-.739 .01
Age 1.028 .999-2.439 .07
Medicare insurance 1.227 1.06-2.67 .45
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Fig 1. Kaplan-Meier curves stratified by race for patients with asymptomatic disease undergoing carotid endarterec-
tomy. Ipsilateral stroke-free rate at 8 years was 94% for black patients (SE 3.4) and 93% for white patients (SE 2.8).
Eight-year stroke-free rate for all strokes was 90% for blacks (SE  4.2) and 89% for whites (SE  3.1). Eight-year
stroke-free survival was 73% for blacks (SE 7.0) and 66% for whites (SE 4.0). W, White patients; B, black patients.
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Fig 2. Kaplan-Meier curves stratified by race for patients with symptomatic disease undergoing carotid endarterec-
tomy. Ipsilateral stroke-free rate at 8 years was 87% for black patients (SE 4.2) and 91% for white patients (SE 2.0).
Eight-year stroke-free rate for all strokes was 66% for blacks (SE  8.1) and 86% for whites (SE  2.4). Eight-year
stroke-free survival was 62% for blacks (SE 7.9) and 65% for whites (SE 3.2). W, White patients; B, black patients.
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Fig 3. Kaplan-Meier curves stratified by race for all patients undergoing carotid endarterectomy. Ipsilateral stroke-free
rate at 8 years was 91% for black patients (SE 2.7) and 92% for white patients (SE 1.6). Eight-year stroke-free rate
for all strokes was 76% for blacks (SE 5.8) and 87% for whites (SE 1.9). Eight-year stroke-free survival was 66% for
blacks (SE  5.9) and 65% for whites (SE  2.5). W, White patients; B, black patients.
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higher rate of strokes in our black cohort.30 White patients
in this series clearly had higher late mortality after CEA than
did black patients. This finding raises the possibility that
blacks who survive long enough to undergo CEA have
overcome the predicted imbalance in mortality and will
enjoy a life expectancy similar to that of whites.
There are acknowledged limitations to retrospective
studies. Referral and selection bias may have affected our
outcomes. Strokes occurring outside of our healthcare sys-
tem may have been missed, particularly in white patients,
who were more likely to have received care in a nonaffiliated
suburban hospital than black patients were. In addition, the
limited number of adverse events in the perioperative pe-
riod and the smaller sample size associated with subgroup
analysis may have affected the predictive power of our
multivariate analysis. Nevertheless, the results of this study
clearly demonstrate that CEA is a safe and effective method
of stroke prevention in black patients. The results in pa-
tients with asymptomatic disease are particularly gratifying
and suggest that more aggressive surveillance of black
patients for carotid bifurcation disease may be warranted.
Black patients with symptomatic disease do have a slightly
worse perioperative outcome, but should not be denied the
benefits of endarterectomy. Symptomatic presentation is
also a predictor of late stroke occurrence and should serve
as a marker of overall increased stroke risk. A more cautious
approach in the preoperative evaluation of patients with
symptomatic disease may be warranted. Future research
efforts should be directed at detection of factors that in-
crease their risk profile. Carotid endarterectomy appears to
be a valuable stroke prevention method in blacks. Black
patients should be appropriately screened for extracranial
carotid artery occlusive disease and considered for CEA
with the same guidelines applied to white patients.
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